20例首诊于眼科的特发性颅内压增高症_Chinese Journal of Ocular Fundus Diseases

Authors：

王一玮 , 汪宇涵 , 马瑾 ,  钟勇 , 杨宁

100730 中国医学科学院北京协和医学院北京协和医院眼科[王一玮(现在河南省眼科研究所河南省立眼科医院郑州大学人民医院眼科)、汪宇涵、马瑾、钟勇]，放射科（杨宁）;

Corresponding author：

钟勇, Email: yzhong_eye@163.com

Keywords：

视乳头水肿; 视野; 神经系统疾病/诊断; 磁共振成像; 血管造影术，数字减影

DOI：

10.3760/cma.j.issn.1005-1015.2017.05.021

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 王一玮, 汪宇涵, 马瑾, 钟勇, 杨宁. 20例首诊于眼科的特发性颅内压增高症. Chinese Journal of Ocular Fundus Diseases, 2017, 33(5): 530-531. doi: 10.3760/cma.j.issn.1005-1015.2017.05.021 Copy

1.	Julayanont P, Karukote A, Ruthirago D, et al. Idiopathic intracranial hypertension: ongoing clinical challenges and future prospects[J]. J Pain Res, 2016, 9: 87-99. doi: 10.2147/JPR.S60633.
2.	Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children[J]. Neurology, 2013, 81(13): 1159-1165. DOI: 10.1212/WNL.0b013e3182a55f17.
3.	Unsold R. Ophthalmological symptoms of idiopathic intracranial hypertension: Importance for diagnosis and clinical course[J]. Ophthalmologe, 2015, 112(10): 808-813. doi: 10.1007/s00347-015-0137-0.
4.	De Simone R, Ranieri A, Bonavita V. Advancement in idiopathic intracranial hypertension pathogenesis: focus on sinus venous stenosis[J]. Neurol Sci, 2010, 31 Suppl 1: S33-39. DOI: 10.1007/s10072-010-0271-z.
5.	Wall M. The importance of visual field testing in idiopathic intracranial hypertension[J]. Continuum (Minneapolis, Minn), 2014, 20(4): 1067-1074. DOI: 10.1212/01.CON.0000453302.20110.29.
6.	Ball AK, Clarke CE. Idiopathic intracranial hypertension[J]. The Lancet Neurol, 2006, 5(5): 433-442. DOI: 10.1016/S1474-4422(06)70442-2.
7.	Baheti NN, Nair M, Thomas SV. Long-term visual outcome in idiopathic intracranial hypertension[J]. Ann Indian Acad Neurol, 2011, 14(1): 19-22. DOI: 10.4103/0972-2327.78044.
8.	Thurtell MJ, Bruce BB, Newman NJ, et al. An update on idiopathic intracranial hypertension[J]. Rev Neurol Dis, 2010, 7(2-3): 56-68.
9.	孙国英, 刘瑛, 高阳, 等. 特发性颅内压增高症[J]. 中华眼底病杂志, 2008, 24(2): 150-154.Sun GY, Liu Y, Gao Y, et al. Idiopathic intracranial hypertension[J]. Chin J Ocul Fundus Dis, 2008, 24(2): 150-154.
10.	Vieira DS, Masruha MR, Goncalves AL, et al. Idiopathic intracranial hypertension with and without papilloedema in a consecutive series of patients with chronic migraine[J]. Cephalalgia, 2008, 28(6): 609-613. DOI: 10.1111/j.1468-2982.2008.01564.x.
11.	Digre KB, Nakamoto BK, Warner JE, et al. A comparison of idiopathic intracranial hypertension with and without papilledema[J]. Headache, 2009, 49(2): 185-193. DOI: 10.1111/j.1526-4610.2008.01324.x.
12.	Thurtell MJ, Newman NJ, Biousse V. Visual loss without papilledema in idiopathic intracranial hypertension[J]. J Neuroophthalmol, 2010, 30(1): 96-98. DOI: 10.1097/WNO.0b013e3181c5d0bc.
13.	Killer HE, Laeng HR, Flammer J, et al. Architecture of arachnoid trabeculae, pillars, and septa in the subarachnoid space of the human optic nerve: anatomy and clinical considerations[J]. Br J Ophthalmol, 2003, 87(6): 777-781. DOI: 10.1136/bjo.87.6.777.
14.	Killer HE, Jaggi GP, Flammer J, et al. Cerebrospinal fluid dynamics between the intracranial and the subarachnoid space of the optic nerve: is it always bidirectional?[J]. Brain, 2007, 130(Pt 2): 514-520. DOI: 10.1093/brain/awl324.
15.	Wall M, Johnson CA, Cello KE, et al. Visual field outcomes for the idiopathic intracranial hypertension treatment trial (IIHTT)[J]. Invest Ophthalmol Vis Sci, 2016, 57(3): 805-812. DOI: 10.1167/iovs.15-18626.
16.	Keltner JL, Johnson CA, Cello KE, et al. Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT)[J]. Invest Ophthalmol Vis Sci, 2014, 55(5): 3200-3207. DOI: 10.1167/iovs.14-14243.

1. Julayanont P, Karukote A, Ruthirago D, et al. Idiopathic intracranial hypertension: ongoing clinical challenges and future prospects[J]. J Pain Res, 2016, 9: 87-99. doi: 10.2147/JPR.S60633.
2. Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children[J]. Neurology, 2013, 81(13): 1159-1165. DOI: 10.1212/WNL.0b013e3182a55f17.
3. Unsold R. Ophthalmological symptoms of idiopathic intracranial hypertension: Importance for diagnosis and clinical course[J]. Ophthalmologe, 2015, 112(10): 808-813. doi: 10.1007/s00347-015-0137-0.
4. De Simone R, Ranieri A, Bonavita V. Advancement in idiopathic intracranial hypertension pathogenesis: focus on sinus venous stenosis[J]. Neurol Sci, 2010, 31 Suppl 1: S33-39. DOI: 10.1007/s10072-010-0271-z.
5. Wall M. The importance of visual field testing in idiopathic intracranial hypertension[J]. Continuum (Minneapolis, Minn), 2014, 20(4): 1067-1074. DOI: 10.1212/01.CON.0000453302.20110.29.
6. Ball AK, Clarke CE. Idiopathic intracranial hypertension[J]. The Lancet Neurol, 2006, 5(5): 433-442. DOI: 10.1016/S1474-4422(06)70442-2.
7. Baheti NN, Nair M, Thomas SV. Long-term visual outcome in idiopathic intracranial hypertension[J]. Ann Indian Acad Neurol, 2011, 14(1): 19-22. DOI: 10.4103/0972-2327.78044.
8. Thurtell MJ, Bruce BB, Newman NJ, et al. An update on idiopathic intracranial hypertension[J]. Rev Neurol Dis, 2010, 7(2-3): 56-68.
9. 孙国英, 刘瑛, 高阳, 等. 特发性颅内压增高症[J]. 中华眼底病杂志, 2008, 24(2): 150-154.Sun GY, Liu Y, Gao Y, et al. Idiopathic intracranial hypertension[J]. Chin J Ocul Fundus Dis, 2008, 24(2): 150-154.
10. Vieira DS, Masruha MR, Goncalves AL, et al. Idiopathic intracranial hypertension with and without papilloedema in a consecutive series of patients with chronic migraine[J]. Cephalalgia, 2008, 28(6): 609-613. DOI: 10.1111/j.1468-2982.2008.01564.x.
11. Digre KB, Nakamoto BK, Warner JE, et al. A comparison of idiopathic intracranial hypertension with and without papilledema[J]. Headache, 2009, 49(2): 185-193. DOI: 10.1111/j.1526-4610.2008.01324.x.
12. Thurtell MJ, Newman NJ, Biousse V. Visual loss without papilledema in idiopathic intracranial hypertension[J]. J Neuroophthalmol, 2010, 30(1): 96-98. DOI: 10.1097/WNO.0b013e3181c5d0bc.
13. Killer HE, Laeng HR, Flammer J, et al. Architecture of arachnoid trabeculae, pillars, and septa in the subarachnoid space of the human optic nerve: anatomy and clinical considerations[J]. Br J Ophthalmol, 2003, 87(6): 777-781. DOI: 10.1136/bjo.87.6.777.
14. Killer HE, Jaggi GP, Flammer J, et al. Cerebrospinal fluid dynamics between the intracranial and the subarachnoid space of the optic nerve: is it always bidirectional?[J]. Brain, 2007, 130(Pt 2): 514-520. DOI: 10.1093/brain/awl324.
15. Wall M, Johnson CA, Cello KE, et al. Visual field outcomes for the idiopathic intracranial hypertension treatment trial (IIHTT)[J]. Invest Ophthalmol Vis Sci, 2016, 57(3): 805-812. DOI: 10.1167/iovs.15-18626.
16. Keltner JL, Johnson CA, Cello KE, et al. Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT)[J]. Invest Ophthalmol Vis Sci, 2014, 55(5): 3200-3207. DOI: 10.1167/iovs.14-14243.

Previous Article
The effect of netrin-1 on activation of Müller cell in diabetes rats
Next Article
532 nm激光光凝联合复方樟柳碱治疗重度非增生型糖尿病视网膜病变的疗效观察

Chinese Journal of Ocular Fundus Diseases

20例首诊于眼科的特发性颅内压增高症

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content